Top Markets
#1 Black Phoenix Black Phoenix +367.56%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.03%
#5 Akedo Akedo +41.87%
#6 Acurast Acurast +35.56%
#7 BasedHype BasedHype +29.98%
#8 GoPlus Security GoPlus Security +22.00%
#9 Cryptopia Cryptopia +21.42%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +21.15%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classement en actions #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Prix de l'action
$0.0202
Dernière synchronisation: 2024-11-19
Capitalisation boursière
$44.67K
Changement (1 jour)
-0.49%
Changement (1 an)
0.00%
Pays
IL
Échange Notable Labs, Ltd. (NTBL)

Catégorie

Healthcare
Ratio P/B pour Notable Labs, Ltd. (NTBL)
Ratio P/B au August 2026 TTM : 0.04
Selon les derniers rapports financiers et le cours de l'action de Notable Labs, Ltd., le ratio cours/valeur comptable actuel (TTM) est 0.04. À la fin de 2022, le ratio P/B était de -0.25.
Historique du ratio P/B pour Notable Labs, Ltd. de 2015 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.04 -86.41%
2023 0.27 -208.34%
2022 -0.25 -99.73%
2021 -93.37 -186.36%
2020 108.12 83.51%
2019 58.92 179.46%
2018 21.08 -82.69%
2017 121.80 21.83%
2016 99.97 -6.40%
2015 106.81 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 16,960.76%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 17,197.82%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 9,801.91%
BE